UCB Canada Joins C$10.8M Epilepsy PGx Development Initiative | GenomeWeb

NEW YORK (GenomeWeb News) – UCB Canada said today it will support a multi-partner research project funded by Genome Canada and Genome Quebec by helping to study the genomes of epilepsy patients and analyzing genes involved in their responses to medications.

Montreal-based UCB said it will use a C$200,000 (US$188,000) grant to fund its contribution to the C$10.8 million project, which launched earlier this year and created the Canadian Epilepsy Network (CENet).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.